Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and v3.5.0 removed, indicating a minor backend update to the site.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag 'Revision: v3.5.0' instead of 'Revision: v3.4.3'. This is a minor version update with no impact on the study information.
    Difference
    0.1%
    Check dated 2026-03-18T18:22:43.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:40:06.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the page removed the government funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:58.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and transactions may not be processed, and that the NIH Clinical Center is open; the site version was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:08:20.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now shows the glossary and updates several metadata labels (e.g., Last Update Submitted that Met QC Criteria) with a new revision label v3.4.0, while some legacy labels and capitalization were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:07:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.